{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":21,"n_cols":5,"rows_kept":21,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910808183403321"]
[null,null,"Autore",null,"Benavides Sandra"]
[null,null,"Titolo",null,"Pediatric pharmacotherapy self assessment / / Sandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others]"]
[null,null,"Pubbl/distr/stampa",null,"Bethesda, Maryland : , : ASHP Publications, , 2015"]
[{"$nulls":4},"©2015"]
[null,null,"ISBN",null,"1-58528-426-2"]
[null,null,"Descrizione fisica",null,"1 online resource (285 p.)"]
[null,null,"Disciplina",null,"615.1083"]
[null,null,"Soggetti",null,"Pediatric pharmacology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"\"\"titlepage\"\"; \"\"table of contents\"\"; \"\"contributors\"\"; \"\"preface\"\"; \"\"acknowledgments\"\"; \"\"1.1 Pediatric Patient Care Management\"\"; \"\"Part One - Cases\"\"; \"\"CASE 2.1  Anaphylaxis | Level 1\"\"; \"\"CASE 2.2  Nutrition | Level 2\"\"; \"\"CASE 2.3 Toxicology | Level 3\"\"; \"\"CASE 3.1 Patent Ductus Arteriosus | Level 1\"\"; \"\"CASE 3.2 Hypertension | Level 2\"\"; \"\"CASE 3.3 Congenital Heart Defects | Level 3\"\"; \"\"CASE 4.1 Asthma | Level 1\"\"; \"\"CASE 4.2 Cystic Fibrosis | Level 2\"\"; \"\"CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3\"\"; \"\"CASE 5.1 Constipation | Level 1\"\""]
[{"$nulls":4},"\"\"CASE 5.2 Crohn Disease | Level 2\"\"\"\"CASE 6.1 Nephrotic Syndrome | Level 2\"\"; \"\"CASE 6.2 Acute Kidney Injury | Level 3\"\"; \"\"CASE 7.1 Type 2 Diabetes Mellitus | Level 1\"\"; \"\"CASE 7.2 Hypothyroidism | Level 2\"\"; \"\"CASE 7.3 Diabetic Ketoacidosis | Level 3\"\"; \"\"CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1\"\"; \"\"CASE 8.2 Autism Spectrum Disorder | Level 2\"\"; \"\"CASE 8.3 Depression | Level 2\"\"; \"\"CASE 8.4 Cerebral Palsy | Level 3\"\"; \"\"CASE 8.5 Seizure Disorders | Level 3\"\"; \"\"CASE 9.1 Acute Otitis Media | Level 1\"\"; \"\"CASE 9.2 Skin and Skin Structure Infections | Level 1\"\""]
[{"$nulls":4},"\"\"CASE 9.3 Parasitic Infections | Level 2\"\"\"\"CASE 9.4 Pneumonia | Level 2\"\"; \"\"CASE 9.5 Kawasaki Disease | Level 3\"\"; \"\"CASE 9.6 Human Immunodeficiency Virus Infection | Level 3\"\"; \"\"CASE 9.7 Meningitis | Level 3\"\"; \"\"CASE 10.1 Anemia | Level 1\"\"; \"\"CASE 10.2 Sickle Cell Disease | Level 2\"\"; \"\"CASE 10.3 Anticoagulation | Level 3\"\"; \"\"PART 2 | QUESTIONS & ANSWERS\"\"; \"\"CASE 2.1 Anaphylaxis | Level 1\"\"; \"\"CASE 2.2 "]
[{"$nulls":4},"Nutrition | Level 2\"\"; \"\"CASE 2.3 Toxicology | Level 3\"\"; \"\"CASE 3.1 Patent Ductus Arteriosus | Level 1\"\"; \"\"CASE 3.2 Hypertension | Level 2\"\""]
[{"$nulls":4},"\"\"CASE 3.3 Congenital Heart Defects | Level 3\"\"\"\"CASE 4.1 Asthma | Level 1\"\"; \"\"CASE 4.2 Cystic Fibrosis | Level 2\"\"; \"\"CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3\"\"; \"\"CASE 5.1 Constipation | Level 1\"\"; \"\"CASE 5.2 Crohn Disease | Level 2\"\"; \"\"CASE 6.1 Nephrotic Syndrome | Level 2\"\"; \"\"CASE 6.2 Acute Kidney Injury | Level 3\"\"; \"\"CASE 7.1 Type 2 Diabetes Mellitus | Level 1\"\"; \"\"CASE 7.2 Hypothyroidism | Level 2\"\"; \"\"CASE 7.3 Diabetic Ketoacidosis | Level 3\"\"; \"\"CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1\"\""]
[{"$nulls":4},"\"\"CASE 8.2 Autism Spectrum Disorder | Level 2\"\"\"\"CASE 8.3 Depression | Level 2\"\"; \"\"CASE 8.4 Cerebral Palsy | Level 3\"\"; \"\"CASE 8.5 Seizure Disorders | Level 3\"\"; \"\"CASE 9.1 Acute Otitis Media | Level 1\"\"; \"\"CASE 9.2 Skin and Skin Structure Infections | Level 1\"\"; \"\"CASE 9.3 Parasitic Infections | Level 2\"\"; \"\"CASE 9.4 Pneumonia | Level 2\"\"; \"\"CASE 9.5 Kawasaki Disease | Level 3\"\"; \"\"CASE 9.6 Human Immunodeficiency Virus Infection | Level 3\"\"; \"\"CASE 9.7 Meningitis | Level 3\"\"; \"\"CASE 10.1 Anemia | Level 1\"\"; \"\"CASE 10.2 Sickle Cell Disease | Level 2\"\"; \"\"CASE 10.3 Anticoagulation | Level 3\"\""]
[{"$nulls":4},"\"\"APPENDIXES\"\""]